NCT00443131View on ClinicalTrials.gov

Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 26, 2007

Primary Completion Date

July 1, 2007

Study Completion Date

July 13, 2007

Conditions
Malaria
Interventions
BIOLOGICAL

GSK Malaria vaccine 257049

Three-dose vaccination by slow intramuscular injection. Three different formulations of this vaccine are tested (without adjuvant, with adjuvant AS01B, with adjuvant AS02A).

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY